Model Development and Prospective Validation to Predict the Response to Neoadjuvant Chemotherapy in Cervical Cancer

NCT01628757 · clinicaltrials.gov ↗

UNKNOWN

Status

1400

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer

Sponsor

Ding Ma

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]